Clinical Guidelines for the use of Palliative Care Drugs in Renal ...
Clinical Guidelines for the use of Palliative Care Drugs in Renal ...
Clinical Guidelines for the use of Palliative Care Drugs in Renal ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Cl<strong>in</strong>ical</strong> <strong>Guidel<strong>in</strong>es</strong> <strong>for</strong> In<strong>for</strong>mation is from <strong>in</strong>dividual data sheets, except, <strong>in</strong> blue = <strong>Renal</strong> Drug Handbook 2 nd<br />
PALLIATIVE CARE DRUGS IN RENAL FAILURE Edition, and <strong>in</strong> green = Micromedex. All o<strong>the</strong>r references are specified.<br />
DRUG<br />
Enoxapar<strong>in</strong><br />
METABOLITES<br />
(A=active,<br />
I=<strong>in</strong>active)<br />
ELIMINATION<br />
(D=drug,<br />
M=metabolites)<br />
Erythromyc<strong>in</strong> Biliary(D)<br />
Fentanyl Norfentalyl (I) D – 9% faecal<br />
D,M - 75% renal<br />
Flucloxacill<strong>in</strong> <strong>Renal</strong> (D)<br />
Fluconazole<br />
Fluoxet<strong>in</strong>e<br />
1,2,3-triazole and<br />
o<strong>the</strong>rs (liver – poor<br />
metab)<br />
Norfluoxet<strong>in</strong>e (A)<br />
(and o<strong>the</strong>r<br />
unidentified M)<br />
<strong>Renal</strong> D,M<br />
(approx. 80%<br />
unchanged)<br />
Ur<strong>in</strong>e
Change language